KR101048148B1 - Method for preparing alpha arbutin using amylosucrase derived from Dinococcus thermos - Google Patents

Method for preparing alpha arbutin using amylosucrase derived from Dinococcus thermos Download PDF

Info

Publication number
KR101048148B1
KR101048148B1 KR1020090086136A KR20090086136A KR101048148B1 KR 101048148 B1 KR101048148 B1 KR 101048148B1 KR 1020090086136 A KR1020090086136 A KR 1020090086136A KR 20090086136 A KR20090086136 A KR 20090086136A KR 101048148 B1 KR101048148 B1 KR 101048148B1
Authority
KR
South Korea
Prior art keywords
leu
ala
arg
asp
gly
Prior art date
Application number
KR1020090086136A
Other languages
Korean (ko)
Other versions
KR20110028169A (en
Inventor
박천석
서동호
정종현
하석진
Original Assignee
경희대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 경희대학교 산학협력단 filed Critical 경희대학교 산학협력단
Priority to KR1020090086136A priority Critical patent/KR101048148B1/en
Publication of KR20110028169A publication Critical patent/KR20110028169A/en
Application granted granted Critical
Publication of KR101048148B1 publication Critical patent/KR101048148B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/46Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y204/00Glycosyltransferases (2.4)
    • C12Y204/01Hexosyltransferases (2.4.1)
    • C12Y204/01004Amylosucrase (2.4.1.4)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

본 발명은 데이노코커스 제오써르말리스(Deinococcus geothermalis)로부터 유래한 아밀로수크라아제를 이용한 알파 알부틴의 제조방법에 관한 것으로, 효소적 합성법에서 일반적으로 사용되는 기질보다 상대적으로 저렴한 기질인 설탕을 사용함으로써, 알부틴보다 멜라닌색소 합성 저해능이 높고, 세포 독성이 적은 특성이 있는 알파 알부틴을 경제적으로 제조할 수 있다. The present invention is Deinococcus The present invention relates to a method for producing alpha arbutin using amylosucrase derived from geothermalis ), and has a higher melanin synthesis inhibitory activity than arbutin by using sugar, which is a relatively inexpensive substrate than a substrate generally used in enzymatic synthesis. Alpha arbutin with low cytotoxic properties can be produced economically.

데이노코커스 제오써르말리스, 설탕, 아밀로수크라아제, 알파 알부틴, 하이드로퀴논, 항산화제 Deinococcus zeomeris, sugar, amylosucrase, alpha arbutin, hydroquinone, antioxidant

Description

데이노코커스 제오써르말리스로부터 유래한 아밀로수크라아제를 이용한 알파 알부틴의 제조방법{Method for production of α-arbutin using amylosucrase from Deinococcus geothermalis}Method for production of alpha-arbutin using amylosucrase from Deinococcus geothermalis}

본 발명은 효소를 이용한 알파-알부틴의 제조방법에 관한 것으로, 더욱 상세하게는 데이노코커스 제오써르말리스(Deinococcus geothermalis)로부터 유래한 아밀로수크라아제를 이용한 알파 알부틴의 제조방법에 관한 것이다. The present invention relates to a method for producing alpha-albutin using an enzyme, and more specifically, Deinococcus It relates to a method for producing alpha arbutin using amylosucrase derived from geothermalis ).

알부틴은 하이드로퀴논(hydroquinone)에 글루코피라노사이드(glucopyranoside)가 베타로 결합된 유도체로서, 멜라닌색소 억제작용이 있어, 피부질환의 치료제 및 피부 미백 물질로 널리 사용되고 있다. Arbutin is a derivative in which glucopyranoside is beta-bound to hydroquinone, and has a melanin-inhibiting action, and is widely used as a therapeutic agent for skin diseases and a skin whitening substance.

한편, 알파 알부틴은 하기 화학식 1에서 보는 바와 같이, 당과 하이드로퀴논이 알파 글루코시딕(α-glycosidic) 결합으로 연결되어 있는 물질로 새로운 미백 원료로 각광을 받고 있다. On the other hand, as shown in the formula (1), alpha arbutin, a substance in which sugar and hydroquinone are connected by alpha glucosidic (α-glycosidic) bonds have been spotlighted as a new whitening raw material.

알파 알부틴은 알부틴과 비교하여 IC50의 값이 10배 이상 낮은 수치를 보일 정도로 티로시나아제(tyrosinase)에 대한 활성 저해가 강하면서도 안정한 화학적 특성을 보이는데, 생체실험에서도 매우 우수한 티로시나아제 저해효과를 보여주고 있다. Alpha-arbutin, is a tyrosinase, while the inhibitory for (tyrosinase) river stable exhibit chemical properties, in vivo in a very good tyrosinase-inhibiting effect so show a lower value of IC 50, compared with arbutin 10 times Is showing.

Figure 112009056178774-pat00001
Figure 112009056178774-pat00001

알파 알부틴은 하이트로퀴논에 당을 전위시키는 효소적 당전이 반응을 통해 합성을 하고 있는데, 당 분자가 전위된 각종 당전이 생성물은 감미의 향상, 용해성 증가, 장내 유용세균 증식 효과, 화학안정성의 증가 등의 기능성이 부가되는 것으로 알려져 있다. Alpha arbutin is synthesized through an enzymatic sugar transfer reaction in which sugar is translocated to hytroquinone. The various sugar transfer products in which sugar molecules have been transduced have improved sweetness, increased solubility, proliferation of intestinal useful bacteria, and increased chemical stability. It is known that such functionality is added.

하이드로퀴논의 당전이 반응은 일본 니시무라(Nishimura) 등이 바실러스 서브틸리스(Bciluus subtilis) X-23 유래 알파-아밀라아제를 이용하여 최초로 성공하였으며, 이 후 알파-글루코시다아제와 트랜스글루코시다아제를 이용하여 알파 알부틴을 합성할 수 있는 보고가 있다. The sugar transition reaction of hydroquinone was carried out by Nishimura et al. ( Bciluus). subtilis ) X-23-derived alpha-amylase was the first success, and there has been a report on the synthesis of alpha arbutin using alpha-glucosidase and transglucosidase.

그런데, 기질로 사용되는 말토펜타오스와 말토오스는 높은 비용이 요구되며, 당전이 산물 외에 여러 산물이 부수적으로 생성되는 등 비경제적인 문제점이 있다.However, maltopentaose and maltose used as substrates are required to have a high cost, and there is an uneconomical problem such that various products are additionally generated in addition to the former products.

한편, 아밀로수크라아제는 설탕을 기질로 사용하여 설탕을 포도당과 과당으 로 가수분해하는 효소인데, 생성된 포도당을 이용하여 알파-1,4-결합의 비수용성 글루칸을 생성하는 것으로 알려져 있다. On the other hand, amylosucrase is an enzyme that hydrolyzes sugar into glucose and fructose by using sugar as a substrate, and it is known to produce alpha-1,4-linked water-insoluble glucan using the produced glucose. .

그런데, 아밀로수크라아제에 관한 연구는 주로 비수용성 글루칸을 생성하는 쪽에 많이 치우쳐 있을 뿐, 이를 사용하여 알파 알부틴을 생산하는 연구는 아직까지 구체적으로 알려진바 없다. By the way, the study of amylosucrase is mainly biased to the production of water-insoluble glucan, the research to produce alpha arbutin using it has not been specifically known yet.

이에 본 발명은 하이드로퀴논과 상대적으로 저렴한 설탕을 기질로 하여 아밀로수크라아제를 첨가하여 효소 반응을 시킴으로써 알파 알부틴을 제조할 수 있는 방법을 개발하여 제공하는데 그 목적이 있다. Accordingly, an object of the present invention is to develop and provide a method for preparing alpha arbutin by performing an enzymatic reaction by adding amylosucrase using hydroquinone and relatively inexpensive sugar as a substrate.

상기 목적을 달성하기 위하여, 본 발명은 설탕 및 하이드로퀴논(hydroquinone)을 기질로 포함하는 반응액에 데이노코커스 제오써르말리스 (Deinococcus geothermalis)로부터 유래한 아밀로수크라아제를 첨가하여 효소 반응시키는 것을 특징으로 하는 알파 알부틴의 제조방법을 제공한다. In order to achieve the above object, the present invention in the reaction solution containing a sugar and hydroquinone (hydroquinone) as a substrate Deinococcus thermalis ( Deinococcus It provides a method for producing alpha arbutin, characterized in that the enzyme reaction by adding amylosucrase derived from geothermalis ).

한편, 본 발명에서 사용하는 데이노코커스 제오써르말리스 (Deinococcus geothermalis)로부터 유래한 아밀로수크라아제는 네이세리아 폴리사카레아(Neiserria polysaccharea) 유래 아밀로수크라아제의 반응 최적 pH가 6.0인 것에 반해 최적 pH가 7.0인데, 기질로 사용되는 하이드로퀴논은 pH 7.0에서 산화될 수 있으므로, 산화를 방지하기 위하여 바람직하게 상기 반응액에 항산화제를 추가로 첨가하는 것이 좋다. 이때, 항산화제는 특정의 것으로 반드시 한정하지 되지 않으나, 일 예로 비타민 C를 사용할 수 있다. On the other hand, amylosucrase derived from Deinococcus geothermalis used in the present invention is Neiserria polysacchareria ( Neiserria) polysaccharea ) derived from amylosucrase, while the optimum pH is 6.0, the optimum pH is 7.0, since the hydroquinone used as the substrate can be oxidized at pH 7.0, in order to prevent oxidation, It is advisable to add additional agents. At this time, the antioxidant is not necessarily limited to a specific one, vitamin C may be used as an example.

한편, 본 발명의 데이노코커스 제오써르말리스(Deinococcus geothermalis)로부터 유래한 아밀로수크라아제는 바람직하게 정제를 위한 태그가 N-말단 또는 C-말 단에 결합되어 있는 것을 사용할 수 있다.On the other hand, Deinococcus Zeolites ( Deinococcus) of the present invention Amylosucrases derived from geothermalis ) can preferably be used in which the tag for purification is bound to the N-terminus or C-terminus.

통상적으로 효소는 이를 코딩하는 유전자가 도입되어 형질전환된 형질전환체로부터 얻어지는데, 해당 효소를 회수하기 위해서는 정제과정을 반드시 거쳐야 한다. 정제 과정에서는 해당 효소의 순도를 높이는 것이 대단히 중요한데, 해당 유전자의 5' 또는 3'에 정제를 위한 태그를 붙이는 방법이 일반적으로 사용되고 있다. 정제용 태그로는 호스트로 사용되는 균주에 포함되어 있는 호스트 단백질들의 pH 특성 등을 고려하여 다양한 것을 선택하여 사용할 수 있는데, 호스트로 대장균을 사용할 경우, 대장균 내 주된 단백질의 pH를 고려할 때, 양이온성 아미노산 태그인 히스-태그(His-tag)를 사용하는 것이 효율적일 수 있다. Typically, the enzyme is obtained from the transformed transformed by introducing the gene encoding the enzyme, it must be purified to recover the enzyme. In the purification process, it is very important to increase the purity of the enzyme, and a method of tagging 5 'or 3' of the gene for purification is generally used. As a tag for purification, various ones can be selected in consideration of the pH characteristics of host proteins included in the strain used as a host. When E. coli is used as a host, cationic is considered when considering the pH of the main protein in E. coli. It may be efficient to use His-tag, an amino acid tag.

한편, 태그를 붙임으로써 해당 효소의 활성이 변하는 경우가 종종 발생하는데, 본 발명에서 확인한 바에 의하면, 본 발명의 데이노코커스 제오써르말리스(Deinococcus geothermalis) 유래 아밀로수크라아제는 히스-태그(His-tag)를 붙여도 활성에는 큰 변화가 없어 사용에 문제가 없는 것으로 확인되었다. On the other hand, the activity of the enzyme is often changed by tagging, as confirmed by the present invention, Deinococcus thermalis of the present invention ( Deinococcus Geothermalis ) -derived amylosukrases showed no significant change in activity even with a his-tag.

본 발명의 알파 알부틴 제조방법은 효소적 합성법에서 사용되는 종래의 기질보다 상대적으로 저렴한 설탕을 기질로 사용함으로써, 알부틴보다 멜라닌색소 합성 저해능이 높고, 세포 독성이 적은 알파 알부틴을 경제적으로 제조할 수 있다. Alpha arbutin production method of the present invention by using a relatively cheaper sugar as a substrate than the conventional substrate used in the enzymatic synthesis method, it is possible to economically produce alpha arbutin with a higher inhibition of melanin synthesis and less cytotoxic than arbutin. .

이하, 본 발명의 내용을 하기 실시예를 통해 더욱 상세히 설명하지만, 본 발명의 권리범위가 하기 실시예에만 한정되는 것은 아니고, 그와 등가의 기술적 사상의 변형까지를 포함한다. Hereinafter, the contents of the present invention will be described in more detail with reference to the following examples, but the scope of the present invention is not limited only to the following examples, and includes modifications of equivalent technical ideas.

한편, 본 발명에서 구체적으로 기재하지 않은 사항은 통상의 유전공학 기술 및 발효 기술을 통해 충분히 달성가능하므로 그에 대한 구체적인 기술은 생략하기로 한다.Meanwhile, matters not specifically described in the present invention may be sufficiently achieved through conventional genetic engineering techniques and fermentation techniques, and thus detailed description thereof will be omitted.

제조예1Preparation Example 1 : : 히스heath -태그(-tag( HisHis -- tag)가tag) 결합한  bound 데이노코커스Daynocaucus 제오써르말리스( Zeo Themalis ( DeinococcusDeinococcus geothermalisgeothermalis ) 유래 재조합 Derived recombination 아밀로수크라아제(amylosucrase)의Amylosucrase 제조 Produce

(1) (One) 아밀로수크라아제를Amylosukrases 암호화하는 Encrypted 폴리뉴클레오타이드를Polynucleotides 포함하는 벡터의 제조 Preparation of Vectors to Include

데이노코커스 제오써르말리스(Deinococcus geothermalis) 유래 아밀로수크라아제를 암호화하는 폴리뉴클레오티드(서열번호 1)는 데이노코커스 제오써르말리스(Deinococcus geothermalis)의 염색체 유전자로부터 분리하여 사용하였고, 그 방법은 하기와 같았다. Deinococcus geothermalis) a polynucleotide (SEQ ID NO: coding for sucrase dehydratase derived as amyl 1) was used to-day furnace separate from the chromosome gene of Lactococcus fifth sseoreu Marlies (Deinococcus geothermalis), the method was as follows.

아밀로수크라아제 유전자의 클로닝을 위해 데이노코커스 제오써르말리스 (Deinococcus geothermalis) DSM 11300의 염색체 DNA를 주형 DNA로 사용하고, 표 1과 같은 서열로 정방향 프라이머 pHCDGAS1 및 역방향 프라이머 pHCDGAS2을 설계한 후, 표 2에 기재된 방법으로 중합효소 연쇄반응(PCR)을 수행하였다. For cloning the amylosucrase gene, chromosomal DNA of Deinococcus geothermalis DSM 11300 was used as template DNA, and the forward primer pHCDGAS1 and reverse primer pHCDGAS2 were designed with the sequence shown in Table 1, Polymerase chain reaction (PCR) was performed by the method described in Table 2.

명칭designation 유전자서열Gene sequence 비고Remarks pHCDGAS1pHCDGAS1 5'- CATATG CTGAAAGACGTGCTCACT-3'5'- CATATG CTGAAAGACGTGCTCACT-3 ' 정방향 프라이머Forward primer pHCDGAS2pHCDGAS2 5'- CTCGAG TGCTGGAGCCTCCCCGGCGGT-3'5'- CTCGAG TGCTGGAGCCTCCCCGGCGGT-3 ' 역방향 프라이머Reverse primer

변성
(denaturation)
denaturalization
(denaturation)
사전 변성(pre-denaturation)Pre-denaturation 95/ 5 min95/5 min
증폭
(amplification)
Amplification
(amplification)
변성(denaturation)Denaturation 95/ 1 min95/1 min 30 회30 times
결합(annealing)Annealing 60/ 1 min60/1 min 확장(extension)Extension 72/ 2 min72/2 min 최종 확장
(final extension)
Final extension
(final extension)
최종 확장(final extension)Final extension 72/ 5 min72/5 min

상기 PCR을 수행한 결과, 벡터 전체를 포함하는 약 1.9 kb의 PCR 산물을 수득하였다. 상기 수득한 PCR 산물을 제한효소 NdeI과 XhoI로 처리된 pGEM-T Easy 벡터와 함께 접합(ligation)하여 pGEM-T-DGAS를 제조하였다. As a result of the PCR, a 1.9 kb PCR product including the whole vector was obtained. The obtained PCR product was conjugated with the pGEM-T Easy vector treated with restriction enzymes Nde I and Xho I to prepare pGEM-T-DGAS.

이 후, 상기 pGEM-T-DGAS를 제한효소 NdeI과 XhoI로 처리하고, 약 1.9 kbp 길이의 조각을 아가로스 전기영동을 통해 분리하여, 동일한 제한 효소로 처리한 pHCEXHD 발현벡터(His tag 포함 벡터)와 함께 라이게이션함으로써 pHCDGAS를 제조하였다. Subsequently, the pGEM-T-DGAS was treated with restriction enzymes Nde I and Xho I, and a fragment of about 1.9 kbp in length was separated by agarose electrophoresis, and the pHCEXHD expression vector (His tag included) was treated with the same restriction enzyme. PHCDGAS was prepared by ligation.

(2) 형질전환체의 제조(2) Preparation of transformant

아밀로수크라아제를 대량 생산하기 위하여, 상기 재조합 벡터 pHCDGAS로 형질전환된 형질전환체를 제조하였다.In order to mass produce amylosucrase, transformants transformed with the recombinant vector pHCDGAS were prepared.

형질전환용 균주(competent cell)화된 이 콜라이(E. coli) MC1061 균주 50 ㎕를 약 30분 정도 얼음에서 녹인 후, 형질전환하고자 하는 재조합 벡터 pHCDGAS가 첨가된 라이게이션 액 1 ㎕를 첨가하여 잘 섞은 다음, 전기충격 큐벳(cuvette)으로 옮긴 후, 전기충격기(Hybaid CelljecT Uno, Hybaid Ltd, UK)로 전기적충격을 주어 형질전환을 수행하였다. 50 μl of the E. coli MC1061 strain transformed into a transformant cell was dissolved on ice for about 30 minutes, and then 1 μl of the ligation solution to which the recombinant vector pHCDGAS to be transformed was added and mixed well. Next, after the transfer to the electric shock cuvette (cuvette), the electric shock with the electric shock (Hybaid CelljecT Uno, Hybaid Ltd, UK) was transformed.

상기 형질전환을 수행한 반응액에 950 ㎕의 LB 액체배지를 첨가하고 37℃에서, 약 40분간 항온배양기에서 배양하였다. 배양 후, 앰피실린(100 ㎍/㎖)이 포함된 LB 한천 배지에 평판 도말하여 내성을 보이는 균주를 1차 선별하였다. To the reaction solution subjected to the transformation, 950 μl of LB liquid medium was added and incubated at 37 ° C. for about 40 minutes in an incubator. After cultivation, strains showing resistance were first selected by plating the plate on LB agar medium containing ampicillin (100 µg / ml).

1차 선별된 균주를 앰피실린이 포함된 LB 액체 배지 5 ㎖에 접종하여 37℃에서 12시간 배양하고, 원심분리하여 균체를 수득하였다. The first selected strains were inoculated in 5 ml of LB liquid medium containing ampicillin, incubated at 37 ° C. for 12 hours, and centrifuged to obtain cells.

이 후, 회수된 균체로부터 플라스미드 분리 키트를 통해 플라스미드를 분리하고 NdeI과 XhoI 제한 효소로 절단하여, 약 1.9 kb의 아밀로수크라아제를 암호화하는 폴리뉴클레오티드가 포함되어 있음을 확인한 1종의 균주를 선별하였다.Thereafter, the plasmids were separated from the recovered cells through a plasmid separation kit and cleaved with Nde I and Xho I restriction enzymes to confirm that a polynucleotide encoding about 1.9 kb of amylosucrase was included. Strains were selected.

(3) (3) HisHis -- tagtag (( 히스heath -태그)가 -Tag) 결합된Combined 재조합  Recombination 아밀로수크라아제의Amylosucrase 정제 refine

상기에서 선별한 형질전환주를 37℃에서 15시간 배양하였다. 배양한 후, 4℃ 및 4,000 rpm의 조건으로 30분 동안 원심분리를 수행하여 균체를 회수하고, 라이시스 버퍼(Lysis buffer) [50mM NaH2PO4, pH 7.0, 300mM NaCl, 10mM imidazole, pH 7.0]에 현탁한 후, 초음파 분쇄하였다. The transformants selected above were incubated at 37 ° C. for 15 hours. After incubation, the cells were recovered by centrifugation at 4 ° C. and 4,000 rpm for 30 minutes. Lysis buffer [Lysis buffer] [50 mM NaH 2 PO 4 , pH 7.0, 300 mM NaCl, 10 mM imidazole, pH 7.0 ], Followed by ultrasonic grinding.

상기 초음파를 이용하여 분쇄한 분쇄액을 4℃ 및 12,000 rpm의 조건으로 10분간 원심분리를 수행한 후, 상등액을 수득하였다. 상기 상등액을 Ni-NTA 친화 크로마토그래피에 주입하여, 재조합 아밀로수크라아제를 정제하였다. The pulverized pulverized liquid using the ultrasonic wave was centrifuged for 10 minutes under conditions of 4 ° C. and 12,000 rpm, and then a supernatant was obtained. The supernatant was injected into Ni-NTA affinity chromatography to purify recombinant amylosucrase.

도 1에 나타난 바와 같이, 정제된 재조합 아밀로수크라아제의 분자량이 이론값과 일치하는 약 75kDa의 분자량을 나타내는 것으로 확인되어, 재조합 아밀로수크라아제 효소가 이 콜라이(E. coli) MC1061에서 성공적으로 발현됨을 확인할 수 있었으며, Ni-NTA 친화성 크로마토그래피 과정을 통하여 효율적으로 정제된다는 것을 확인할 수 있었다. As shown in Fig. 1, is showed a molecular weight of about 75kDa, which is the molecular weight of the sucrase azepin with purified recombinant amyl match the theoretical value, this is sucrase enzyme in recombinant E.coli-amyl (E. coli) It was confirmed that it was successfully expressed in MC1061, it was confirmed that it is efficiently purified through the Ni-NTA affinity chromatography process.

실시예Example 1; 알파 알부틴의 제조 및 정제 One; Preparation and Purification of Alpha Arbutin

알파 알부틴의 제조를 위해 사용된 하이드로퀴논과 설탕은 시그마(Sigma Chemical Co.; St. Louis, MO. USA)로부터 구입하였다. 하이드로퀴논 25 g/L, 설탕 50 g/L를 Tris-Cl 완충용액(pH 7.0)에 혼합한 후, 상기 제조예 1로부터 정제된 재조합 아밀로수크라아제 효소 10 U/ml을 첨가하고 35℃에서 15시간 동안 반응시켰다. 반응 후 5분 동안 용액을 끓이고, 왓트만 여지를 이용하여 여과하였다. Hydroquinone and sugar used for the preparation of alpha arbutin were purchased from Sigma Chemical Co .; St. Louis, Mo. USA. After mixing 25 g / L of hydroquinone and 50 g / L of sugar in Tris-Cl buffer (pH 7.0), 10 U / ml of the recombinant amylosucrase enzyme purified from Preparation Example 1 was added thereto, and 35 ° C. Reaction was carried out for 15 hours. The solution was boiled for 5 minutes after the reaction and filtered using Whatman filter paper.

이후, 하기 실험예에서 반응생성물을 분석하였다.Then, the reaction product was analyzed in the following experimental example.

실시예Example 2; 알파 알부틴의 제조 및 정제 2; Preparation and Purification of Alpha Arbutin

알파 알부틴의 제조를 위해 사용된 하이드로퀴논과 설탕은 시그마(Sigma Chemical Co.; St. Louis, MO. USA)로부터 구입하였다. 하이드로퀴논 25 g/L, 설탕 50 g/L를 Tris-Cl 완충용액(pH 7.0)에 혼합한 후, 상기 제조예 1로부터 정제된 재조합 아밀로수크라아제 효소 10 U/ml을 첨가하고 35℃에서 15시간 동안 반응시켰다. Hydroquinone and sugar used for the preparation of alpha arbutin were purchased from Sigma Chemical Co .; St. Louis, Mo. USA. After mixing 25 g / L of hydroquinone and 50 g / L of sugar in Tris-Cl buffer (pH 7.0), 10 U / ml of the recombinant amylosucrase enzyme purified from Preparation Example 1 was added thereto, and 35 ° C. Reaction was carried out for 15 hours.

한편, 기질인 하이드로퀴논의 산화를 방지하기 위해서 4 g/L의 아스코빈 산(비타민 C)을 첨가해 주고, 반응 후 5분 동안 용액을 끓이고, 왓트만 여지를 이용하여 여과하였다. On the other hand, in order to prevent the oxidation of the hydroquinone substrate 4 g / L of ascorbic acid (vitamin C) was added, the solution was boiled for 5 minutes after the reaction, and filtered using Whatman filter.

이후, 하기 실험예에서 반응생성물을 분석하였다.Then, the reaction product was analyzed in the following experimental example.

실험예Experimental Example 1;  One; 박막크로마토그래피를Thin layer chromatography 이용한 반응생성물의 분석 Analysis of the reaction product used

실시예 1 및 실시예 2의 반응에서 얻어진 반응생성물을 분석하기 위해서 박막크로마토그래피를 수행하였다. Thin layer chromatography was performed to analyze the reaction products obtained in the reactions of Examples 1 and 2.

실시예 1 및 실시예 2의 반응생성물을 Merck 60 F254 TLC 플레이트(20 cm × 20 cm)에 1 ㎕씩 로딩하여 에틸아세테이트:아세트산:증류수=3:1:1 전개액에서 전개시켰다. 전개 후에 플레이트를 잘 건조시켜 메탄올에 0.3 %(w/v) N-(1-나프틸)-에틸렌디아민과 5 %(v/v) 황산을 용해시킨 발색액에 담갔다가 꺼낸 후 110℃ 오븐에서 10분 동안 발색시켰다. The reaction products of Examples 1 and 2 were loaded in 1 μl each of Merck 60 F 254 TLC plates (20 cm × 20 cm) and developed in ethyl acetate: acetic acid: distilled water = 3: 1: 1 developing solution. After development, the plate was well dried, soaked in a coloring solution in which 0.3% (w / v) N- (1-naphthyl) -ethylenediamine and 5% (v / v) sulfuric acid was dissolved in methanol, and then taken out in a 110 ° C oven. Color development for 10 minutes.

도 2에서 보듯이, 아스코빈 산(비타민 C)가 첨가되지 않은 실시예 1의 반응물과 아스코빈 산(비타민 C)가 첨가된 실시예 2의 반응물에서 공히 하이드로퀴논에 당이 전이되어 알파 알부틴이 생성된 것을 확인할 수 있었다. 다만, 아스코빈 산(비타민 C)을 반응액에 첨가시켜 반응을 시킨 경우, 그렇지 않은 경우에 비해 알파 알부틴의 양이 많이 생성되는 것으로 확인되었다. As shown in FIG. 2, the sugars were transferred to the hydroquinone in the reaction product of Example 1, in which the ascorbic acid (vitamin C) was not added, and the reaction product of Example 2, in which the ascorbic acid (vitamin C) was added, to give alpha arbutin. It was confirmed that the generated. However, when the reaction was performed by adding ascorbic acid (vitamin C) to the reaction solution, it was confirmed that a greater amount of alpha arbutin was produced than otherwise.

실험예Experimental Example 2;  2; 고성능액체크로마토그래피를High performance liquid chromatography 이용한 반응생성물의 분석 Analysis of the reaction product used

실시예 2에서 얻은 반응생성물을 고성능액체크로마토그래피(HPLC)를 이용하여 분석하였다. 시료를 실시예 2에서 얻은 반응생성물을 0.45 ㎛ 박막여과지로 여과하여 25 ㎕를 주입하였고, 유속은 1.0 ml/분으로 하여 분석하였다. HPLC 분석은 시마즈(일본)의 LC-AD 그래디언트 펌프와 SPD-10A 검출기 및 LC-NH2 컬럼 (SUPELCOSILTM)을 이용하여 시행하였으며, 용매는 A 용액(아세트나이트릴), B 용액(물)을 9:1로 혼합하여 사용하였다. The reaction product obtained in Example 2 was analyzed using high performance liquid chromatography (HPLC). The reaction product obtained in Example 2 was filtered through a 0.45 µm thin film filter paper and 25 µl was injected, and the flow rate was analyzed at 1.0 ml / min. HPLC analysis was carried out using a Shimadzu LC-AD gradient pump, SPD-10A detector and LC-NH2 column (SUPELCOSIL TM ), and the solvent was A solution (acetonitrile) and B solution (water). The mixture was used as 1: 1.

결과는 도 3과 같았는데, 알파 알부틴이 제조되었음을 확인할 수 있었다. The results were as shown in Figure 3, it was confirmed that the alpha arbutin was prepared.

실험예Experimental Example 3; ' 3; ' FastFast AtomAtom BombardmentBombardment MassMass Spectroscopy'Spectroscopy ' 를 이용한 알파 알부틴의 분자량 측정Molecular Weight Measurement of Alpha Arbutin

실시예 2에서 얻은 반응생성물의 분자량을 확인하기 위해서 FABMS(Fast atom bombardment mass spectroscopy: JEOL JMS 700, Japan)을 사용하였다. 분석결과, 실시예 2에서 얻은 반응생성물은 271.1 [M-H]-에 나타나는 이온 피크로부터 시료의 분자량이 272.1으로 측정되었다. In order to confirm the molecular weight of the reaction product obtained in Example 2 FABMS (Fast atom bombardment mass spectroscopy: JEOL JMS 700, Japan) was used. As a result of the analysis, the reaction product obtained in Example 2 had a molecular weight of 272.1 as the molecular weight of the sample from the ionic peak at 271.1 [MH] .

이로부터 반응 생성물이 알파 알부틴의 분자량과 일치함을 알 수가 있다.This shows that the reaction product is consistent with the molecular weight of alpha arbutin.

실험예Experimental Example 4;  4; 1One H 및 H and 1313 C C NMRNMR 을 이용한 알파 알부틴의 구조분석Analysis of Alpha Arbutin Using

실시예 2에서 얻은 반응생성물의 구조를 확인하기 위하여 1H 및 13C 핵자기공명분석(NMR; Varian, USA)을 알부틴과 비교하여 수행하였다. 시료는 실시예 2에서 순수 정제한 반응생성물을 중수(D2O)에 용해시켜 사용하였다. In order to confirm the structure of the reaction product obtained in Example 2 1 H and 13 C nuclear magnetic resonance analysis (NMR; Varian, USA) was performed by comparing with arbutin. The sample was used by dissolving the purely purified reaction product in Example 2 in heavy water (D 2 O).

결과는 표 3과 같았다. COSY, HMQC 및 HMBC 실험결과로부터 반응생성물은 알파 알부틴임을 알 수 있었다. 하기 표 3은 본 발명에 따른 알부틴과 알파 알부틴에 대한 1H 및 13C NMR 을 이용한 구조분석결과를 나타낸 것이다.The results were shown in Table 3. COSY, HMQC and HMBC experiments showed that the reaction product was alpha arbutin. Table 3 below shows the structural analysis results using 1 H and 13 C NMR for arbutin and alpha arbutin according to the present invention.

Figure 112009056178774-pat00002
Figure 112009056178774-pat00002

도 1은 정제된 재조합 아밀로수크라아제를 보여주는 전기영동 사진이다. 1 is an electrophoretic photograph showing purified recombinant amylosucrase.

도 2는 박막크로마토그래피를 이용한 본 발명의 반응생성물 분석결과를 보여준다. Figure 2 shows the reaction product analysis results of the present invention using thin film chromatography.

도 3은 HPLC를 이용한 본 발명의 반응생성물 분석결과를 보여준다. Figure 3 shows the analysis of the reaction product of the present invention using HPLC.

<110> University-Industry Cooperation Group of Kyung Hee University <120> Method for production of alpha-arbutin using amylosucrase from Deinococcus geothermalis <160> 2 <170> KopatentIn 1.71 <210> 1 <211> 1950 <212> DNA <213> Deinococcus geothermalis <220> <221> CDS <222> (1)..(1950) <400> 1 atg ctg aaa gac gtg ctc act tct gaa ctg gcg gcg cag gta cga gac 48 Met Leu Lys Asp Val Leu Thr Ser Glu Leu Ala Ala Gln Val Arg Asp 1 5 10 15 gcc ttc gat gat gac cgt gac gcc gag acg ttc ctg ctg cgg ctg gaa 96 Ala Phe Asp Asp Asp Arg Asp Ala Glu Thr Phe Leu Leu Arg Leu Glu 20 25 30 cgc tac ggc gag gac ctc tgg gag agc ctg cgc gcg gtg tat ggc gac 144 Arg Tyr Gly Glu Asp Leu Trp Glu Ser Leu Arg Ala Val Tyr Gly Asp 35 40 45 cag gtg agg gcc ttg cca ggg cga ctg ctg gaa gtc atg ctc cac gcc 192 Gln Val Arg Ala Leu Pro Gly Arg Leu Leu Glu Val Met Leu His Ala 50 55 60 tat cac gcc cgc ccc gcg gag ctg cgg cgt ttg gac gag gcc cgg ctg 240 Tyr His Ala Arg Pro Ala Glu Leu Arg Arg Leu Asp Glu Ala Arg Leu 65 70 75 80 ctg cgg ccc gac tgg ctg caa cgt ccc gag atg gtg ggc tac gtc gcc 288 Leu Arg Pro Asp Trp Leu Gln Arg Pro Glu Met Val Gly Tyr Val Ala 85 90 95 tac acc gac cgt ttt gcc gga acg ctg aag ggg gta gag gag cgc ttg 336 Tyr Thr Asp Arg Phe Ala Gly Thr Leu Lys Gly Val Glu Glu Arg Leu 100 105 110 gac tac ctg gag ggc ctg ggt gtg aag tac ctg cac ctg atg ccc ctt 384 Asp Tyr Leu Glu Gly Leu Gly Val Lys Tyr Leu His Leu Met Pro Leu 115 120 125 ctc agg ccg cgc gag ggc gaa aat gac ggt ggc tac gcg gtg cag gat 432 Leu Arg Pro Arg Glu Gly Glu Asn Asp Gly Gly Tyr Ala Val Gln Asp 130 135 140 tac cga gcg gtg cgt ccc gac ctg ggc acg atg gat gac ctc tcg gcc 480 Tyr Arg Ala Val Arg Pro Asp Leu Gly Thr Met Asp Asp Leu Ser Ala 145 150 155 160 ctc gcg cgg gcg ctg cgg ggc cgc ggc atc agc ctg gtg ctg gat ctc 528 Leu Ala Arg Ala Leu Arg Gly Arg Gly Ile Ser Leu Val Leu Asp Leu 165 170 175 gtg ctg aac cac gtg gcg cgc gaa cat gcg tgg gcc cag aag gcg cgg 576 Val Leu Asn His Val Ala Arg Glu His Ala Trp Ala Gln Lys Ala Arg 180 185 190 gcg ggt gat ccc aag tac cgg gcc tac ttt cat ctc ttc ccc gac cgc 624 Ala Gly Asp Pro Lys Tyr Arg Ala Tyr Phe His Leu Phe Pro Asp Arg 195 200 205 agg ggg ccg gac gct ttt gaa gcc acc ctt cct gag atc ttt ccc gac 672 Arg Gly Pro Asp Ala Phe Glu Ala Thr Leu Pro Glu Ile Phe Pro Asp 210 215 220 ttc gcg ccg ggc aac ttc tcg tgg gac gag gag atc ggt gaa ggc gag 720 Phe Ala Pro Gly Asn Phe Ser Trp Asp Glu Glu Ile Gly Glu Gly Glu 225 230 235 240 ggg ggc tgg gtc tgg acc acc ttc aac agc tac cag tgg gac ctg aac 768 Gly Gly Trp Val Trp Thr Thr Phe Asn Ser Tyr Gln Trp Asp Leu Asn 245 250 255 tgg gcc aac ccc gac gtg ttt ctg gag ttt gtg gac atc atc ctc tac 816 Trp Ala Asn Pro Asp Val Phe Leu Glu Phe Val Asp Ile Ile Leu Tyr 260 265 270 ctc gcc aac cgg ggc gtg gag gtg ttc cgg ctg gat gcg atc gcc ttc 864 Leu Ala Asn Arg Gly Val Glu Val Phe Arg Leu Asp Ala Ile Ala Phe 275 280 285 atc tgg aag cgg ctg gga acc gac tgc caa aac cag ccg gaa gtt cac 912 Ile Trp Lys Arg Leu Gly Thr Asp Cys Gln Asn Gln Pro Glu Val His 290 295 300 cac ctc acg cgg gcg ctg cgg gca gcc gcg cgc atc gtc gcg ccc gca 960 His Leu Thr Arg Ala Leu Arg Ala Ala Ala Arg Ile Val Ala Pro Ala 305 310 315 320 gtc gcc ttt aag gcc gag gcg atc gtg gcg ccc gcc gac ctg atc cac 1008 Val Ala Phe Lys Ala Glu Ala Ile Val Ala Pro Ala Asp Leu Ile His 325 330 335 tac ctg ggc acc cgt gcg cac cac ggc aag gtg agc gac atg gcc tac 1056 Tyr Leu Gly Thr Arg Ala His His Gly Lys Val Ser Asp Met Ala Tyr 340 345 350 cac aac agc ctg atg gtg cag ctg tgg agt agc ctc gcc agc cgg aat 1104 His Asn Ser Leu Met Val Gln Leu Trp Ser Ser Leu Ala Ser Arg Asn 355 360 365 acc cgt ctc ttt gag gag gca ctg cgg gcg ttt ccc ccc aag ccc acg 1152 Thr Arg Leu Phe Glu Glu Ala Leu Arg Ala Phe Pro Pro Lys Pro Thr 370 375 380 agc acg acc tgg ggg ctg tac gtc cgc tgt cac gac gac atc ggc tgg 1200 Ser Thr Thr Trp Gly Leu Tyr Val Arg Cys His Asp Asp Ile Gly Trp 385 390 395 400 gcc atc agc gac gag gac gcg gcc cgg gcc gga ttg aac ggc gcg gcg 1248 Ala Ile Ser Asp Glu Asp Ala Ala Arg Ala Gly Leu Asn Gly Ala Ala 405 410 415 cac cgg cac ttt ctc tcg gac ttc tac agc ggt cag ttt ccc ggc tcc 1296 His Arg His Phe Leu Ser Asp Phe Tyr Ser Gly Gln Phe Pro Gly Ser 420 425 430 ttt gcg cgg ggg ctg gtg ttt cag tac aac ccg gtg aac ggc gac cgg 1344 Phe Ala Arg Gly Leu Val Phe Gln Tyr Asn Pro Val Asn Gly Asp Arg 435 440 445 cgc atc agt ggc tcg gcg gcc agc ctc gct ggg ctg gag gca gcg ctg 1392 Arg Ile Ser Gly Ser Ala Ala Ser Leu Ala Gly Leu Glu Ala Ala Leu 450 455 460 gaa acc ggg gac ccg ggc cgc atc gag gac gcg gtg cgt cgc ctg ctg 1440 Glu Thr Gly Asp Pro Gly Arg Ile Glu Asp Ala Val Arg Arg Leu Leu 465 470 475 480 ctc ctc cac acg gtc att ctc ggc ttc ggc ggg gtg ccg ctg ctg tac 1488 Leu Leu His Thr Val Ile Leu Gly Phe Gly Gly Val Pro Leu Leu Tyr 485 490 495 atg ggc gac gaa ctc gcc ctg ctg aat gac tac gcc ttc gag gac gtg 1536 Met Gly Asp Glu Leu Ala Leu Leu Asn Asp Tyr Ala Phe Glu Asp Val 500 505 510 ccc gaa cac gcg ccg gac aac cgc tgg gtg cat cgc ccg cag atg gat 1584 Pro Glu His Ala Pro Asp Asn Arg Trp Val His Arg Pro Gln Met Asp 515 520 525 tgg gcc ctc gcg gag cgg gtg cgg cag gag cct tcc tcg ccc gcc gga 1632 Trp Ala Leu Ala Glu Arg Val Arg Gln Glu Pro Ser Ser Pro Ala Gly 530 535 540 cgg gtg aac acg ggc ctg cgc cac ctc ctg cgg gtg cgc cgc gat acc 1680 Arg Val Asn Thr Gly Leu Arg His Leu Leu Arg Val Arg Arg Asp Thr 545 550 555 560 ccg cag ctg cac gcc agc atc gag agc cag gtg ctg ccc agc ccc gat 1728 Pro Gln Leu His Ala Ser Ile Glu Ser Gln Val Leu Pro Ser Pro Asp 565 570 575 tcg cgt gcg ctt ctg ctg cgc cgc gac cat ccc ctc ggc ggg atg gtg 1776 Ser Arg Ala Leu Leu Leu Arg Arg Asp His Pro Leu Gly Gly Met Val 580 585 590 cag gtg tac aac ttc agc gag gag acg gtg atg ctg ccc agc cat gtt 1824 Gln Val Tyr Asn Phe Ser Glu Glu Thr Val Met Leu Pro Ser His Val 595 600 605 ctg cgg gac gtg ctg ggg gac cac gtc cag gac cgg ctg agc ggg agt 1872 Leu Arg Asp Val Leu Gly Asp His Val Gln Asp Arg Leu Ser Gly Ser 610 615 620 gcc ttt cgc cta gat cgg ccc acc gtt cgc ctg gag ggc tac cgg gca 1920 Ala Phe Arg Leu Asp Arg Pro Thr Val Arg Leu Glu Gly Tyr Arg Ala 625 630 635 640 ctg tgg ctg acc gcc ggg gag gct cca gca 1950 Leu Trp Leu Thr Ala Gly Glu Ala Pro Ala 645 650 <210> 2 <211> 650 <212> PRT <213> Deinococcus geothermalis <400> 2 Met Leu Lys Asp Val Leu Thr Ser Glu Leu Ala Ala Gln Val Arg Asp 1 5 10 15 Ala Phe Asp Asp Asp Arg Asp Ala Glu Thr Phe Leu Leu Arg Leu Glu 20 25 30 Arg Tyr Gly Glu Asp Leu Trp Glu Ser Leu Arg Ala Val Tyr Gly Asp 35 40 45 Gln Val Arg Ala Leu Pro Gly Arg Leu Leu Glu Val Met Leu His Ala 50 55 60 Tyr His Ala Arg Pro Ala Glu Leu Arg Arg Leu Asp Glu Ala Arg Leu 65 70 75 80 Leu Arg Pro Asp Trp Leu Gln Arg Pro Glu Met Val Gly Tyr Val Ala 85 90 95 Tyr Thr Asp Arg Phe Ala Gly Thr Leu Lys Gly Val Glu Glu Arg Leu 100 105 110 Asp Tyr Leu Glu Gly Leu Gly Val Lys Tyr Leu His Leu Met Pro Leu 115 120 125 Leu Arg Pro Arg Glu Gly Glu Asn Asp Gly Gly Tyr Ala Val Gln Asp 130 135 140 Tyr Arg Ala Val Arg Pro Asp Leu Gly Thr Met Asp Asp Leu Ser Ala 145 150 155 160 Leu Ala Arg Ala Leu Arg Gly Arg Gly Ile Ser Leu Val Leu Asp Leu 165 170 175 Val Leu Asn His Val Ala Arg Glu His Ala Trp Ala Gln Lys Ala Arg 180 185 190 Ala Gly Asp Pro Lys Tyr Arg Ala Tyr Phe His Leu Phe Pro Asp Arg 195 200 205 Arg Gly Pro Asp Ala Phe Glu Ala Thr Leu Pro Glu Ile Phe Pro Asp 210 215 220 Phe Ala Pro Gly Asn Phe Ser Trp Asp Glu Glu Ile Gly Glu Gly Glu 225 230 235 240 Gly Gly Trp Val Trp Thr Thr Phe Asn Ser Tyr Gln Trp Asp Leu Asn 245 250 255 Trp Ala Asn Pro Asp Val Phe Leu Glu Phe Val Asp Ile Ile Leu Tyr 260 265 270 Leu Ala Asn Arg Gly Val Glu Val Phe Arg Leu Asp Ala Ile Ala Phe 275 280 285 Ile Trp Lys Arg Leu Gly Thr Asp Cys Gln Asn Gln Pro Glu Val His 290 295 300 His Leu Thr Arg Ala Leu Arg Ala Ala Ala Arg Ile Val Ala Pro Ala 305 310 315 320 Val Ala Phe Lys Ala Glu Ala Ile Val Ala Pro Ala Asp Leu Ile His 325 330 335 Tyr Leu Gly Thr Arg Ala His His Gly Lys Val Ser Asp Met Ala Tyr 340 345 350 His Asn Ser Leu Met Val Gln Leu Trp Ser Ser Leu Ala Ser Arg Asn 355 360 365 Thr Arg Leu Phe Glu Glu Ala Leu Arg Ala Phe Pro Pro Lys Pro Thr 370 375 380 Ser Thr Thr Trp Gly Leu Tyr Val Arg Cys His Asp Asp Ile Gly Trp 385 390 395 400 Ala Ile Ser Asp Glu Asp Ala Ala Arg Ala Gly Leu Asn Gly Ala Ala 405 410 415 His Arg His Phe Leu Ser Asp Phe Tyr Ser Gly Gln Phe Pro Gly Ser 420 425 430 Phe Ala Arg Gly Leu Val Phe Gln Tyr Asn Pro Val Asn Gly Asp Arg 435 440 445 Arg Ile Ser Gly Ser Ala Ala Ser Leu Ala Gly Leu Glu Ala Ala Leu 450 455 460 Glu Thr Gly Asp Pro Gly Arg Ile Glu Asp Ala Val Arg Arg Leu Leu 465 470 475 480 Leu Leu His Thr Val Ile Leu Gly Phe Gly Gly Val Pro Leu Leu Tyr 485 490 495 Met Gly Asp Glu Leu Ala Leu Leu Asn Asp Tyr Ala Phe Glu Asp Val 500 505 510 Pro Glu His Ala Pro Asp Asn Arg Trp Val His Arg Pro Gln Met Asp 515 520 525 Trp Ala Leu Ala Glu Arg Val Arg Gln Glu Pro Ser Ser Pro Ala Gly 530 535 540 Arg Val Asn Thr Gly Leu Arg His Leu Leu Arg Val Arg Arg Asp Thr 545 550 555 560 Pro Gln Leu His Ala Ser Ile Glu Ser Gln Val Leu Pro Ser Pro Asp 565 570 575 Ser Arg Ala Leu Leu Leu Arg Arg Asp His Pro Leu Gly Gly Met Val 580 585 590 Gln Val Tyr Asn Phe Ser Glu Glu Thr Val Met Leu Pro Ser His Val 595 600 605 Leu Arg Asp Val Leu Gly Asp His Val Gln Asp Arg Leu Ser Gly Ser 610 615 620 Ala Phe Arg Leu Asp Arg Pro Thr Val Arg Leu Glu Gly Tyr Arg Ala 625 630 635 640 Leu Trp Leu Thr Ala Gly Glu Ala Pro Ala 645 650 <110> University-Industry Cooperation Group of Kyung Hee University <120> Method for production of alpha-arbutin using amylosucrase from          Deinococcus geothermalis <160> 2 <170> KopatentIn 1.71 <210> 1 <211> 1950 <212> DNA <213> Deinococcus geothermalis <220> <221> CDS (222) (1) .. (1950) <400> 1 atg ctg aaa gac gtg ctc act tct gaa ctg gcg gcg cag gta cga gac 48 Met Leu Lys Asp Val Leu Thr Ser Glu Leu Ala Ala Gln Val Arg Asp   1 5 10 15 gcc ttc gat gat gac cgt gac gcc gag acg ttc ctg ctg cgg ctg gaa 96 Ala Phe Asp Asp Asp Arg Asp Ala Glu Thr Phe Leu Leu Arg Leu Glu              20 25 30 cgc tac ggc gag gac ctc tgg gag agc ctg cgc gcg gtg tat ggc gac 144 Arg Tyr Gly Glu Asp Leu Trp Glu Ser Leu Arg Ala Val Tyr Gly Asp          35 40 45 cag gtg agg gcc ttg cca ggg cga ctg ctg gaa gtc atg ctc cac gcc 192 Gln Val Arg Ala Leu Pro Gly Arg Leu Leu Glu Val Met Leu His Ala      50 55 60 tat cac gcc cgc ccc gcg gag ctg cgg cgt ttg gac gag gcc cgg ctg 240 Tyr His Ala Arg Pro Ala Glu Leu Arg Arg Leu Asp Glu Ala Arg Leu  65 70 75 80 ctg cgg ccc gac tgg ctg caa cgt ccc gag atg gtg ggc tac gtc gcc 288 Leu Arg Pro Asp Trp Leu Gln Arg Pro Glu Met Val Gly Tyr Val Ala                  85 90 95 tac acc gac cgt ttt gcc gga acg ctg aag ggg gta gag gag cgc ttg 336 Tyr Thr Asp Arg Phe Ala Gly Thr Leu Lys Gly Val Glu Glu Arg Leu             100 105 110 gac tac ctg gag ggc ctg ggt gtg aag tac ctg cac ctg atg ccc ctt 384 Asp Tyr Leu Glu Gly Leu Gly Val Lys Tyr Leu His Leu Met Pro Leu         115 120 125 ctc agg ccg cgc gag ggc gaa aat gac ggt ggc tac gcg gtg cag gat 432 Leu Arg Pro Arg Glu Gly Glu Asn Asp Gly Gly Tyr Ala Val Gln Asp     130 135 140 tac cga gcg gtg cgt ccc gac ctg ggc acg atg gat gac ctc tcg gcc 480 Tyr Arg Ala Val Arg Pro Asp Leu Gly Thr Met Asp Asp Leu Ser Ala 145 150 155 160 ctc gcg cgg gcg ctg cgg ggc cgc ggc atc agc ctg gtg ctg gat ctc 528 Leu Ala Arg Ala Leu Arg Gly Arg Gly Ile Ser Leu Val Leu Asp Leu                 165 170 175 gtg ctg aac cac gtg gcg cgc gaa cat gcg tgg gcc cag aag gcg cgg 576 Val Leu Asn His Val Ala Arg Glu His Ala Trp Ala Gln Lys Ala Arg             180 185 190 gcg ggt gat ccc aag tac cgg gcc tac ttt cat ctc ttc ccc gac cgc 624 Ala Gly Asp Pro Lys Tyr Arg Ala Tyr Phe His Leu Phe Pro Asp Arg         195 200 205 agg ggg ccg gac gct ttt gaa gcc acc ctt cct gag atc ttt ccc gac 672 Arg Gly Pro Asp Ala Phe Glu Ala Thr Leu Pro Glu Ile Phe Pro Asp     210 215 220 ttc gcg ccg ggc aac ttc tcg tgg gac gag gag atc ggt gaa ggc gag 720 Phe Ala Pro Gly Asn Phe Ser Trp Asp Glu Glu Ile Gly Glu Gly Glu 225 230 235 240 ggg ggc tgg gtc tgg acc acc ttc aac agc tac cag tgg gac ctg aac 768 Gly Gly Trp Val Trp Thr Thr Phe Asn Ser Tyr Gln Trp Asp Leu Asn                 245 250 255 tgg gcc aac ccc gac gtg ttt ctg gag ttt gtg gac atc atc ctc tac 816 Trp Ala Asn Pro Asp Val Phe Leu Glu Phe Val Asp Ile Ile Leu Tyr             260 265 270 ctc gcc aac cgg ggc gtg gag gtg ttc cgg ctg gat gcg atc gcc ttc 864 Leu Ala Asn Arg Gly Val Glu Val Phe Arg Leu Asp Ala Ile Ala Phe         275 280 285 atc tgg aag cgg ctg gga acc gac tgc caa aac cag ccg gaa gtt cac 912 Ile Trp Lys Arg Leu Gly Thr Asp Cys Gln Asn Gln Pro Glu Val His     290 295 300 cac ctc acg cgg gcg ctg cgg gca gcc gcg cgc atc gtc gcg ccc gca 960 His Leu Thr Arg Ala Leu Arg Ala Ala Ala Arg Ile Val Ala Pro Ala 305 310 315 320 gtc gcc ttt aag gcc gag gcg atc gtg gcg ccc gcc gac ctg atc cac 1008 Val Ala Phe Lys Ala Glu Ala Ile Val Ala Pro Ala Asp Leu Ile His                 325 330 335 tac ctg ggc acc cgt gcg cac cac ggc aag gtg agc gac atg gcc tac 1056 Tyr Leu Gly Thr Arg Ala His His Gly Lys Val Ser Asp Met Ala Tyr             340 345 350 cac aac agc ctg atg gtg cag ctg tgg agt agc ctc gcc agc cgg aat 1104 His Asn Ser Leu Met Val Gln Leu Trp Ser Ser Leu Ala Ser Arg Asn         355 360 365 acc cgt ctc ttt gag gag gca ctg cgg gcg ttt ccc ccc aag ccc acg 1152 Thr Arg Leu Phe Glu Glu Ala Leu Arg Ala Phe Pro Pro Lys Pro Thr     370 375 380 agc acg acc tgg ggg ctg tac gtc cgc tgt cac gac gac atc ggc tgg 1200 Ser Thr Thr Trp Gly Leu Tyr Val Arg Cys His Asp Asp Ile Gly Trp 385 390 395 400 gcc atc agc gac gag gac gcg gcc cgg gcc gga ttg aac ggc gcg gcg 1248 Ala Ile Ser Asp Glu Asp Ala Ala Arg Ala Gly Leu Asn Gly Ala Ala                 405 410 415 cac cgg cac ttt ctc tcg gac ttc tac agc ggt cag ttt ccc ggc tcc 1296 His Arg His Phe Leu Ser Asp Phe Tyr Ser Gly Gln Phe Pro Gly Ser             420 425 430 ttt gcg cgg ggg ctg gtg ttt cag tac aac ccg gtg aac ggc gac cgg 1344 Phe Ala Arg Gly Leu Val Phe Gln Tyr Asn Pro Val Asn Gly Asp Arg         435 440 445 cgc atc agt ggc tcg gcg gcc agc ctc gct ggg ctg gag gca gcg ctg 1392 Arg Ile Ser Gly Ser Ala Ala Ser Leu Ala Gly Leu Glu Ala Ala Leu     450 455 460 gaa acc ggg gac ccg ggc cgc atc gag gac gcg gtg cgt cgc ctg ctg 1440 Glu Thr Gly Asp Pro Gly Arg Ile Glu Asp Ala Val Arg Arg Leu Leu 465 470 475 480 ctc ctc cac acg gtc att ctc ggc ttc ggc ggg gtg ccg ctg ctg tac 1488 Leu Leu His Thr Val Ile Leu Gly Phe Gly Gly Val Pro Leu Leu Tyr                 485 490 495 atg ggc gac gaa ctc gcc ctg ctg aat gac tac gcc ttc gag gac gtg 1536 Met Gly Asp Glu Leu Ala Leu Leu Asn Asp Tyr Ala Phe Glu Asp Val             500 505 510 ccc gaa cac gcg ccg gac aac cgc tgg gtg cat cgc ccg cag atg gat 1584 Pro Glu His Ala Pro Asp Asn Arg Trp Val His Arg Pro Gln Met Asp         515 520 525 tgg gcc ctc gcg gag cgg gtg cgg cag gag cct tcc tcg ccc gcc gga 1632 Trp Ala Leu Ala Glu Arg Val Arg Gln Glu Pro Ser Ser Pro Ala Gly     530 535 540 cgg gtg aac acg ggc ctg cgc cac ctc ctg cgg gtg cgc cgc gat acc 1680 Arg Val Asn Thr Gly Leu Arg His Leu Leu Arg Val Arg Arg Asp Thr 545 550 555 560 ccg cag ctg cac gcc agc atc gag agc cag gtg ctg ccc agc ccc gat 1728 Pro Gln Leu His Ala Ser Ile Glu Ser Gln Val Leu Pro Ser Pro Asp                 565 570 575 tcg cgt gcg ctt ctg ctg cgc cgc gac cat ccc ctc ggc ggg atg gtg 1776 Ser Arg Ala Leu Leu Leu Arg Arg Asp His Pro Leu Gly Gly Met Val             580 585 590 cag gtg tac aac ttc agc gag gag acg gtg atg ctg ccc agc cat gtt 1824 Gln Val Tyr Asn Phe Ser Glu Glu Thr Val Met Leu Pro Ser His Val         595 600 605 ctg cgg gac gtg ctg ggg gac cac gtc cag gac cgg ctg agc ggg agt 1872 Leu Arg Asp Val Leu Gly Asp His Val Gln Asp Arg Leu Ser Gly Ser     610 615 620 gcc ttt cgc cta gat cgg ccc acc gtt cgc ctg gag ggc tac cgg gca 1920 Ala Phe Arg Leu Asp Arg Pro Thr Val Arg Leu Glu Gly Tyr Arg Ala 625 630 635 640 ctg tgg ctg acc gcc ggg gag gct cca gca 1950 Leu Trp Leu Thr Ala Gly Glu Ala Pro Ala                 645 650 <210> 2 <211> 650 <212> PRT <213> Deinococcus geothermalis <400> 2 Met Leu Lys Asp Val Leu Thr Ser Glu Leu Ala Ala Gln Val Arg Asp   1 5 10 15 Ala Phe Asp Asp Asp Arg Asp Ala Glu Thr Phe Leu Leu Arg Leu Glu              20 25 30 Arg Tyr Gly Glu Asp Leu Trp Glu Ser Leu Arg Ala Val Tyr Gly Asp          35 40 45 Gln Val Arg Ala Leu Pro Gly Arg Leu Leu Glu Val Met Leu His Ala      50 55 60 Tyr His Ala Arg Pro Ala Glu Leu Arg Arg Leu Asp Glu Ala Arg Leu  65 70 75 80 Leu Arg Pro Asp Trp Leu Gln Arg Pro Glu Met Val Gly Tyr Val Ala                  85 90 95 Tyr Thr Asp Arg Phe Ala Gly Thr Leu Lys Gly Val Glu Glu Arg Leu             100 105 110 Asp Tyr Leu Glu Gly Leu Gly Val Lys Tyr Leu His Leu Met Pro Leu         115 120 125 Leu Arg Pro Arg Glu Gly Glu Asn Asp Gly Gly Tyr Ala Val Gln Asp     130 135 140 Tyr Arg Ala Val Arg Pro Asp Leu Gly Thr Met Asp Asp Leu Ser Ala 145 150 155 160 Leu Ala Arg Ala Leu Arg Gly Arg Gly Ile Ser Leu Val Leu Asp Leu                 165 170 175 Val Leu Asn His Val Ala Arg Glu His Ala Trp Ala Gln Lys Ala Arg             180 185 190 Ala Gly Asp Pro Lys Tyr Arg Ala Tyr Phe His Leu Phe Pro Asp Arg         195 200 205 Arg Gly Pro Asp Ala Phe Glu Ala Thr Leu Pro Glu Ile Phe Pro Asp     210 215 220 Phe Ala Pro Gly Asn Phe Ser Trp Asp Glu Glu Ile Gly Glu Gly Glu 225 230 235 240 Gly Gly Trp Val Trp Thr Thr Phe Asn Ser Tyr Gln Trp Asp Leu Asn                 245 250 255 Trp Ala Asn Pro Asp Val Phe Leu Glu Phe Val Asp Ile Ile Leu Tyr             260 265 270 Leu Ala Asn Arg Gly Val Glu Val Phe Arg Leu Asp Ala Ile Ala Phe         275 280 285 Ile Trp Lys Arg Leu Gly Thr Asp Cys Gln Asn Gln Pro Glu Val His     290 295 300 His Leu Thr Arg Ala Leu Arg Ala Ala Ala Arg Ile Val Ala Pro Ala 305 310 315 320 Val Ala Phe Lys Ala Glu Ala Ile Val Ala Pro Ala Asp Leu Ile His                 325 330 335 Tyr Leu Gly Thr Arg Ala His His Gly Lys Val Ser Asp Met Ala Tyr             340 345 350 His Asn Ser Leu Met Val Gln Leu Trp Ser Ser Leu Ala Ser Arg Asn         355 360 365 Thr Arg Leu Phe Glu Glu Ala Leu Arg Ala Phe Pro Pro Lys Pro Thr     370 375 380 Ser Thr Thr Trp Gly Leu Tyr Val Arg Cys His Asp Asp Ile Gly Trp 385 390 395 400 Ala Ile Ser Asp Glu Asp Ala Ala Arg Ala Gly Leu Asn Gly Ala Ala                 405 410 415 His Arg His Phe Leu Ser Asp Phe Tyr Ser Gly Gln Phe Pro Gly Ser             420 425 430 Phe Ala Arg Gly Leu Val Phe Gln Tyr Asn Pro Val Asn Gly Asp Arg         435 440 445 Arg Ile Ser Gly Ser Ala Ala Ser Leu Ala Gly Leu Glu Ala Ala Leu     450 455 460 Glu Thr Gly Asp Pro Gly Arg Ile Glu Asp Ala Val Arg Arg Leu Leu 465 470 475 480 Leu Leu His Thr Val Ile Leu Gly Phe Gly Gly Val Pro Leu Leu Tyr                 485 490 495 Met Gly Asp Glu Leu Ala Leu Leu Asn Asp Tyr Ala Phe Glu Asp Val             500 505 510 Pro Glu His Ala Pro Asp Asn Arg Trp Val His Arg Pro Gln Met Asp         515 520 525 Trp Ala Leu Ala Glu Arg Val Arg Gln Glu Pro Ser Ser Pro Ala Gly     530 535 540 Arg Val Asn Thr Gly Leu Arg His Leu Leu Arg Val Arg Arg Asp Thr 545 550 555 560 Pro Gln Leu His Ala Ser Ile Glu Ser Gln Val Leu Pro Ser Pro Asp                 565 570 575 Ser Arg Ala Leu Leu Leu Arg Arg Asp His Pro Leu Gly Gly Met Val             580 585 590 Gln Val Tyr Asn Phe Ser Glu Glu Thr Val Met Leu Pro Ser His Val         595 600 605 Leu Arg Asp Val Leu Gly Asp His Val Gln Asp Arg Leu Ser Gly Ser     610 615 620 Ala Phe Arg Leu Asp Arg Pro Thr Val Arg Leu Glu Gly Tyr Arg Ala 625 630 635 640 Leu Trp Leu Thr Ala Gly Glu Ala Pro Ala                 645 650  

Claims (5)

설탕 및 하이드로퀴논(hydroquinone)을 기질로 포함하는 반응액에 데이노코커스 제오써르말리스(Deinococcus geothermalis)로부터 유래한 아밀로수크라아제를 첨가하여 효소 반응시키는 것을 특징으로 하는 알파 알부틴의 제조방법 Deinococcus in a reaction solution containing sugar and hydroquinone as a substrate. Method for preparing alpha arbutin, characterized in that the enzyme reaction by adding amylosucrase derived from geothermalis ) 제1항에 있어서,The method of claim 1, 상기 반응액에,To the reaction solution, 하이드로퀴논의 산화를 방지하기 위해 항산화제를 추가로 첨가하는 것을 특징으로 하는 알파 알부틴의 제조방법 Method for producing alpha arbutin, characterized in that additional antioxidant is added to prevent oxidation of hydroquinone 제2항에 있어서,The method of claim 2, 상기 항산화제는,The antioxidant, 비타민 C 인 것을 특징으로 하는 알파 알부틴의 제조방법Method for producing alpha arbutin, characterized in that vitamin C 제1항에 있어서, The method of claim 1, 상기 데이노코커스 제오써르말리스(Deinococcus geothermalis)로부터 유래한 아밀로수크라아제는, Deinococcus amylosucrase derived from geothermalis ), 정제를 위한 태그가 N-말단 또는 C-말단에 결합되어 있는 것을 특징으로 하는 알파 알부틴의 제조방법Method for producing alpha arbutin, characterized in that the tag for purification is bound to the N- or C-terminus 제4항에 있어서, 5. The method of claim 4, 상기 태그는, The tag is, 히드-태그(His-tag)인 것을 특징으로 하는 알파 알부틴의 제조방법Method for producing alpha arbutin, characterized in that the (His-tag)
KR1020090086136A 2009-09-11 2009-09-11 Method for preparing alpha arbutin using amylosucrase derived from Dinococcus thermos KR101048148B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020090086136A KR101048148B1 (en) 2009-09-11 2009-09-11 Method for preparing alpha arbutin using amylosucrase derived from Dinococcus thermos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020090086136A KR101048148B1 (en) 2009-09-11 2009-09-11 Method for preparing alpha arbutin using amylosucrase derived from Dinococcus thermos

Publications (2)

Publication Number Publication Date
KR20110028169A KR20110028169A (en) 2011-03-17
KR101048148B1 true KR101048148B1 (en) 2011-07-11

Family

ID=43934657

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020090086136A KR101048148B1 (en) 2009-09-11 2009-09-11 Method for preparing alpha arbutin using amylosucrase derived from Dinococcus thermos

Country Status (1)

Country Link
KR (1) KR101048148B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017123072A1 (en) * 2016-01-15 2017-07-20 씨제이제일제당(주) New polyphosphate-dependent glucokinase and method for producing glucose 6-phosphate using same

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107267478A (en) * 2017-06-30 2017-10-20 江南大学 A kind of amylosucrase and its method for converting production α ursin
CN107828752B (en) * 2017-11-07 2020-12-08 山东阳成生物科技有限公司 Saccharopolyase, preparation method and application in production of alpha-arbutin
KR102050507B1 (en) * 2017-11-15 2019-11-29 한국식품연구원 Preparation Method of Luteolin Glucoside
CN109988800A (en) * 2019-03-18 2019-07-09 合肥华恒生物工程有限公司 A method of hydroquinone conversion ratio is improved using superoxide dismutase

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020095422A (en) * 2001-06-14 2002-12-26 주식회사 엔지켐 Process for the preparation of arbutin derivatives
KR20080077913A (en) * 2007-02-21 2008-08-26 전남대학교산학협력단 Method for preparing derivatives of glyco-compounds by using glycosyltransferases and the derivatives thereof
KR20090081491A (en) * 2008-01-24 2009-07-29 경희대학교 산학협력단 Method for preparing of an arbutin derivative by using amylosucrase from Deinococcus georthermails and the derivatives thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020095422A (en) * 2001-06-14 2002-12-26 주식회사 엔지켐 Process for the preparation of arbutin derivatives
KR20080077913A (en) * 2007-02-21 2008-08-26 전남대학교산학협력단 Method for preparing derivatives of glyco-compounds by using glycosyltransferases and the derivatives thereof
KR20090081491A (en) * 2008-01-24 2009-07-29 경희대학교 산학협력단 Method for preparing of an arbutin derivative by using amylosucrase from Deinococcus georthermails and the derivatives thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017123072A1 (en) * 2016-01-15 2017-07-20 씨제이제일제당(주) New polyphosphate-dependent glucokinase and method for producing glucose 6-phosphate using same
US11274326B2 (en) 2016-01-15 2022-03-15 Cj Cheiljedang Corporation Polyphosphate-dependent glucokinase and method for producing glucose 6-phosphate using same

Also Published As

Publication number Publication date
KR20110028169A (en) 2011-03-17

Similar Documents

Publication Publication Date Title
JP6479084B2 (en) A series of glycosyltransferases and their applications
KR101550796B1 (en) Manufacturing method for tagatose
CN107641621B (en) Glycosidase composition and method for preparing icariin by enzyme method
KR101048148B1 (en) Method for preparing alpha arbutin using amylosucrase derived from Dinococcus thermos
BR112019020230A2 (en) COMPOSITION TO PRODUCE TAGATOSIS AND METHOD OF PRODUCING TAGATOSIS WITH THE SAME USE
US8192956B2 (en) Hybrid genes and enzymes of glucanase and dextransucrase and processes for preparing isomalto-oligosaccharides or dextran using the same
TWI700370B (en) A composition for producing tagatose and methods for producing tagatose using the same
KR102076288B1 (en) A composition for preparing tagatose and Methods for producing tagatose using The Same
KR101455624B1 (en) Novel D-psicose-3-epimerase from Clostridium bolteae having production of functional rare sugar D-psicose and production method of D-psicose using thereof
AU2016427130B2 (en) Method for preparing rebaudioside N using enzymatic method
CN107446874B (en) Recombinant escherichia coli and application thereof in synthesizing rebaudioside D
KR101177218B1 (en) Preparation method of turanose using amylosucrase and sweetner using turanose
CN101955952B (en) Bacterial laccase gene and expression and application thereof
KR100374448B1 (en) DNA encoding enzymes, recombinant DNA (DNA) and enzymes, transformants and methods of making them
KR101708974B1 (en) Novel sucrose isomerase and process for preparing the same
CN111621488A (en) Heat-adaptability-improved inulase exonuclease mutant MutQ23 delta 11
CN111455003A (en) Method for preparing D-psicose from microalgae
KR100941695B1 (en) Method for preparing of alpha-D-glucopyranosyl-1?4-arbutin by using amylosucrase from Deinococcus georthermails
CN111575260B (en) Application of SAM dependent methyltransferase DmtMT2-1
KR101768748B1 (en) Mutated sucrose isomerase and process for preparing the same
KR102232837B1 (en) Novel polypeptides having glucosylglycerol productivity and a method for producing glucosylglycerol using the same
Chung et al. Enzymatic synthesis of dTDP-4-amino-4, 6-dideoxy-D-glucose using GerB (dTDP-4-keto-6-deoxy-D-glucose aminotransferase)
KR940003652B1 (en) Method of preparing of polypeptide possessing cyclomaltodextrin glucano transferase activity
CN108148824B (en) Organic solvent-resistant efficient galactosidase and application thereof
CN116445519B (en) Glycosyltransferase and application thereof in biosynthesis of eugenol glucoside

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20140617

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20150617

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee